Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/57312 |
Resumo: | We would like to thank Izaı´ra Tincani Branda˜o and Ana Paula Masson for the general technical assistance provided, as well as Ana Maria da Rocha for her technical assistance in processing the histological sections. This study received financial support from the Fundac¸ão de Amparo a Pesquisa do Estado de São Paulo (FAPESP, Foundation for the Support of Research in the State of Sa˜o Paulo; grant no. 03/11303-2 and 00/09663-2), the Conselho Nacional de Desenvolvimento Cientı´fico e Tecnolo´ gico (CNPq, Council for Scientific and Technological Development), and the Rede Brasileira de Pesquisa em TB (Rede-TB, Brazilian Tuberculosis Research Network). |
id |
CRUZ_733ecc6581476e73bc3cc0a648ef75de |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/57312 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Fonseca, Denise Morais daSilva, Célio LopesPaula, Marina Oliveira eSoares, Edson GarciaMarchal, GillesHorn, CynthiaBonato, Vânia Luiza Deperon2023-03-09T02:44:00Z2023-03-09T02:44:00Z2007FONSECA, Denise Morais da et al. Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection. Immunology, Oxford, v. 121, n. 4, p. 508-517, Aug. 2007.1365-2567https://www.arca.fiocruz.br/handle/icict/5731210.1111/j.1365-2567.2007.02597.x1365-2567We would like to thank Izaı´ra Tincani Branda˜o and Ana Paula Masson for the general technical assistance provided, as well as Ana Maria da Rocha for her technical assistance in processing the histological sections. This study received financial support from the Fundac¸ão de Amparo a Pesquisa do Estado de São Paulo (FAPESP, Foundation for the Support of Research in the State of Sa˜o Paulo; grant no. 03/11303-2 and 00/09663-2), the Conselho Nacional de Desenvolvimento Cientı´fico e Tecnolo´ gico (CNPq, Council for Scientific and Technological Development), and the Rede Brasileira de Pesquisa em TB (Rede-TB, Brazilian Tuberculosis Research Network).University of São Paulo. Ribeirão Preto School of Medicine. Department of Biochemistry and Immunology. Tuberculosis Research Centre. Ribeirão Preto, SP, Brazil.University of São Paulo. Ribeirão Preto School of Medicine. Department of Biochemistry and Immunology. Tuberculosis Research Centre. Ribeirão Preto, SP, Brazil.University of São Paulo. Ribeirão Preto School of Medicine. Department of Biochemistry and Immunology. Tuberculosis Research Centre. Ribeirão Preto, SP, Brazil.University of São Paulo. Ribeirão Preto School of Medicine. Department of Pathology. Ribeirão Preto, SP, Brazil.Institute Pasteur. Laboratoire de Référence des Mycobacteries. Paris, France.Oswaldo Cruz Foundation. Evandro Chagas Clinical Research Institute. Rio de Janeiro, RJ, Brazil.University of São Paulo. Ribeirão Preto School of Medicine. Department of Biochemistry and Immunology. Tuberculosis Research Centre. Ribeirão Preto, SP, Brazil.The results of various animal model studies of tuberculosis (TB) suggest that culture filtrate proteins (CFPs), which are antigens secreted by Mycobacterium tuberculosis, are largely responsible for improvements in TB vaccines. The great obstacle to developing protein subunit vaccines is that adjuvants are required in order to stimulate relevant protective immune responses. Acting as immune adjuvants, CpG-oligodeoxynucleotides (CpG-ODNs) promote the activation of Th1 cells and of pro-inflammatory cytokines. To evaluate the adjuvant role of CpG-ODNs in conferring enhanced immunogenic capacity and protection against M. tuberculosis, we immunized mice with CFP antigen combined with synthetic CpG-ODNs (CFP/CpG) or with incomplete Freund's adjuvant (IFA) (CFP/IFA). Immunization with CFP/CpG induced a T helper 1 (Th1)-biased response accompanied by a higher immunoglobulin G2a (IgG2a) antibody/IgG1 antibody ratio, elevated production of interferon-gamma (IFN-gamma) by spleen cells and in lungs. However, CFP/IFA-immunized mice presented higher levels of IgG1 antibodies, as well as increased production of IFN-gamma, interleukin (IL)-5, and IL-10 by spleen cells, together with lower levels of IFN-gamma in the lungs. Despite the stronger Th1 response seen in both groups, believed to be necessary for protection against TB, only mice immunized with CFP/IFA were protected after M. tuberculosis infection. Lung histology revealed that lung parenchyma were better preserved in CFP/IFA-immunized mice, which also presented intense lymphocyte recruitment to the lesion, whereas CFP/CpG-immunized mice presented severe pulmonary injury accompanied by necrosis. Based on the data presented, we discuss the widely accepted paradigm that high levels of IFN-gamma are directly correlated with protection against experimental TB.engWiley Online LibraryIncreased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infectioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleTuberculosisCulture filtrate proteinsCpG oligodeoxynucleotidesVaccineAdjuvantinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALve_Fonseca_Denise_etal_INI_2007.pdfve_Fonseca_Denise_etal_INI_2007.pdfapplication/pdf604897https://www.arca.fiocruz.br/bitstream/icict/57312/2/ve_Fonseca_Denise_etal_INI_2007.pdfd1b636a5d4010982cf49fab73ed2a6c3MD52LICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/57312/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51icict/573122023-03-08 23:47:49.796oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-09T02:47:49Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.en_US.fl_str_mv |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection |
title |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection |
spellingShingle |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection Fonseca, Denise Morais da Tuberculosis Culture filtrate proteins CpG oligodeoxynucleotides Vaccine Adjuvant |
title_short |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection |
title_full |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection |
title_fullStr |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection |
title_full_unstemmed |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection |
title_sort |
Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection |
author |
Fonseca, Denise Morais da |
author_facet |
Fonseca, Denise Morais da Silva, Célio Lopes Paula, Marina Oliveira e Soares, Edson Garcia Marchal, Gilles Horn, Cynthia Bonato, Vânia Luiza Deperon |
author_role |
author |
author2 |
Silva, Célio Lopes Paula, Marina Oliveira e Soares, Edson Garcia Marchal, Gilles Horn, Cynthia Bonato, Vânia Luiza Deperon |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Fonseca, Denise Morais da Silva, Célio Lopes Paula, Marina Oliveira e Soares, Edson Garcia Marchal, Gilles Horn, Cynthia Bonato, Vânia Luiza Deperon |
dc.subject.en.en_US.fl_str_mv |
Tuberculosis Culture filtrate proteins CpG oligodeoxynucleotides Vaccine Adjuvant |
topic |
Tuberculosis Culture filtrate proteins CpG oligodeoxynucleotides Vaccine Adjuvant |
description |
We would like to thank Izaı´ra Tincani Branda˜o and Ana Paula Masson for the general technical assistance provided, as well as Ana Maria da Rocha for her technical assistance in processing the histological sections. This study received financial support from the Fundac¸ão de Amparo a Pesquisa do Estado de São Paulo (FAPESP, Foundation for the Support of Research in the State of Sa˜o Paulo; grant no. 03/11303-2 and 00/09663-2), the Conselho Nacional de Desenvolvimento Cientı´fico e Tecnolo´ gico (CNPq, Council for Scientific and Technological Development), and the Rede Brasileira de Pesquisa em TB (Rede-TB, Brazilian Tuberculosis Research Network). |
publishDate |
2007 |
dc.date.issued.fl_str_mv |
2007 |
dc.date.accessioned.fl_str_mv |
2023-03-09T02:44:00Z |
dc.date.available.fl_str_mv |
2023-03-09T02:44:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
FONSECA, Denise Morais da et al. Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection. Immunology, Oxford, v. 121, n. 4, p. 508-517, Aug. 2007. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/57312 |
dc.identifier.issn.en_US.fl_str_mv |
1365-2567 |
dc.identifier.doi.none.fl_str_mv |
10.1111/j.1365-2567.2007.02597.x |
dc.identifier.eissn.none.fl_str_mv |
1365-2567 |
identifier_str_mv |
FONSECA, Denise Morais da et al. Increased levels of interferon-c primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection. Immunology, Oxford, v. 121, n. 4, p. 508-517, Aug. 2007. 1365-2567 10.1111/j.1365-2567.2007.02597.x |
url |
https://www.arca.fiocruz.br/handle/icict/57312 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Wiley Online Library |
publisher.none.fl_str_mv |
Wiley Online Library |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/57312/2/ve_Fonseca_Denise_etal_INI_2007.pdf https://www.arca.fiocruz.br/bitstream/icict/57312/1/license.txt |
bitstream.checksum.fl_str_mv |
d1b636a5d4010982cf49fab73ed2a6c3 8a4605be74aa9ea9d79846c1fba20a33 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009198502379520 |